Patents Assigned to Samyang Genexbio Corporation
  • Method for preparing highly pure anhydrous crystalline docetaxel
    Patent number: 8410294
    Abstract: A method for preparing highly pure anhydrous crystalline docetaxel is provided. The method for preparing highly pure anhydrous crystalline docetaxel enables preparation of anhydrous crystalline docetaxel that has purity of 99.5% or more, and is useful as an anticancer agent due to remarkably low residual solvent content compared to the standard of residual solvents in drugs.
    Type: Grant
    Filed: December 27, 2010
    Date of Patent: April 2, 2013
    Assignee: Samyang Genexbio Corporation
    Inventors: Jin-Suk Cho, Moon-Suk Kim, Jai-Young Song, Jeong-Hwan Yun, Jong-Won Yoon, Ho-Joon Choi
  • METHOD FOR PREPARING HIGHLY PURE ANHYDROUS CRYSTALLINE DOCETAXEL
    Publication number: 20130046104
    Abstract: A method for preparing highly pure anhydrous crystalline docetaxel is provided. The method for preparing highly pure anhydrous crystalline docetaxel enables preparation of anhydrous crystalline docetaxel that has purity of 99.5% or more, and is useful as an anticancer agent due to remarkably low residual solvent content compared to the standard of residual solvents in drugs.
    Type: Application
    Filed: December 27, 2010
    Publication date: February 21, 2013
    Applicant: Samyang Genexbio Corporation
    Inventors: Jin-Suk Cho, Moon-Suk Kim, Jai-Young Song, Jeong-Hwan Yun, Jong-Won Yoon, Ho-Joon Choi